M. Ah-See

Greater Anti-Angiogenic Effects with Docetaxel Compared with Anthracyclines in the Neoadjuvant Treatment of Breast Cancer.

D. Collins, A. Padhani, A. Makris, 2009 .

The relationship of the neo-angiogenic marker, endoglin, with response to neoadjuvant chemotherapy in breast cancer

A. Harris, A. Makris, F. Daley, 2006, British Journal of Cancer.

Evaluation of FLT-PET-CT as an imaging biomarker of proliferation in primary breast cancer

S Detre, M. Dowsett, B. Sanghera, 2014, British Journal of Cancer.

MRI correlates of tumour grade and hypoxia status in human breast cancer

A. Harris, D. Collins, A. Padhani, 2005 .

Pre-treatment haemoglobin levels and the prediction of response to neoadjuvant chemotherapy in breast cancer.

A. Makris, D. Stott, M. Beresford, 2006, Clinical oncology (Royal College of Radiologists (Great Britain)).